» Articles » PMID: 20007681

Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease

Overview
Specialty Nephrology
Date 2009 Dec 17
PMID 20007681
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Chronic kidney disease (CKD) increases systemic inflammation, which is implicated in development and maintenance of atrial fibrillation (AF); therefore, we hypothesized that the prevalence of AF would be increased among nondialysis patients with CKD. This study also reports independent predictors of the presence of AF in this population.

Design, Setting, Participants, & Measurements: A retrospective, cross-sectional analysis of 1010 consecutive nondialysis patients with CKD from two community-based hospitals was conducted. Estimated GFRs (eGFRs) were calculated using the Modification of Diet in Renal Disease (MDRD) equation. Multivariate logistic regression was used to determine independent predictors.

Results: Of 1010 nondialysis patients with CKD, 214 (21.2%) had AF. Patients with AF were older than patients without AF (76 +/- 11 versus 63 +/- 15 yr). The prevalence of AF among white patients (42.7%) was higher than among black patients (12.7%) or other races (5.7%). In multivariate analyses, age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure were identified as independent predictors of the presence of AF. Although serum high-sensitivity C-reactive protein levels were elevated in our population (5.2 +/- 7.4 mg/L), levels did not correlate with the presence of AF or with eGFR. Finally, eGFR did not correlate with the presence of AF in our population.

Conclusions: The prevalence of AF was increased in our population, and independent predictors were age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure.

Citing Articles

High premature atrial complex burden and risk of renal function decline.

Chen C, Yu C, Lee P, Huang M, Chiu P, Su P Clin Kidney J. 2024; 17(8):sfae208.

PMID: 39421240 PMC: 11483494. DOI: 10.1093/ckj/sfae208.


Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients.

Gan Y, Nie S, Pang M, Huang R, Xu H, Liu B Clin Kidney J. 2024; 17(8):sfae137.

PMID: 39131078 PMC: 11316397. DOI: 10.1093/ckj/sfae137.


Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.

Parks A, Stevens S, Woller S Thromb Res. 2024; 241:109097.

PMID: 39094333 PMC: 11418398. DOI: 10.1016/j.thromres.2024.109097.


Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020.

Liaw J, Liaw D, Dave C Open Heart. 2024; 11(1).

PMID: 38302138 PMC: 10831461. DOI: 10.1136/openhrt-2023-002515.


Effectiveness and safety of apixaban and rivaroxaban warfarin in patients with atrial fibrillation and chronic kidney disease.

Perreault S, Boivin Proulx L, Lenglet A, Massy Z, Dorais M World J Nephrol. 2024; 12(5):132-146.

PMID: 38230301 PMC: 10789087. DOI: 10.5527/wjn.v12.i5.132.


References
1.
Shlipak M, Fried L, Crump C, Bleyer A, Manolio T, Tracy R . Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003; 107(1):87-92. DOI: 10.1161/01.cir.0000042700.48769.59. View

2.
Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T . The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98(5):476-84. DOI: 10.1016/S0002-9343(99)80348-9. View

3.
Buch P, Friberg J, Scharling H, Lange P, Prescott E . Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003; 21(6):1012-6. DOI: 10.1183/09031936.03.00051502. View

4.
Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

5.
Aviles R, Martin D, Apperson-Hansen C, Houghtaling P, Rautaharju P, Kronmal R . Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108(24):3006-10. DOI: 10.1161/01.CIR.0000103131.70301.4F. View